Clinical Trial Update: PRO-POWER: Hypertension With Risk Factors for a Duration of 24 Weeks With Micardis 80mg/Micardis Plus 80mg/12.5mg

View source ↗

Summary

This entry reports the completion and posting of results for the PRO-POWER trial evaluating telmisartan (Micardis) with or without hydrochlorothiazide in hypert…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Micardis (telmisartan)
• Micardis Plus (telmisartan/hydrochlorothiazide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Status: COMPLETED | Results posted: 2012-07-02